These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21716223)

  • 1. [Antioxidant protection as a component of anesthetic management cancer patients].
    Tumanian SV; Ivanova LG
    Khirurgiia (Mosk); 2011; (6):66-9. PubMed ID: 21716223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antioxidant protection in surgical correction of inborn heart disease with the use of artificial circulation].
    Bakhareva IuA; Nadiradze ZZ
    Khirurgiia (Mosk); 2011; (5):61-5. PubMed ID: 21666584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
    Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
    Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correction of metabolic disturbances in cancer patients in the early postanesthesia period].
    Fatullaeva KF; Nurov AU; Saltanov AI
    Khirurgiia (Mosk); 2010; (4):54-7. PubMed ID: 20521428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correction of a reperfusion dysfunction in acute intestinal obstruction].
    Bagnenko SF; Sinenchenko GI; Kurygin AA; Chupris VG
    Vestn Khir Im I I Grek; 2008; 167(4):32-5. PubMed ID: 18942433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant therapy in discirculatory encephalopathy].
    Antipenko EA; Gustov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytoflavin in total intravenous anesthesia].
    Ovezov AM; Bragina SV; Prokoshev PV
    Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
    Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
    Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
    Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
    Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative correction of the methabolism of the single lung after pulmonectomy].
    Iakovlev AIu; Gordeeva OS; Denisenko AN; Vorontsov AIu; Ulitin DN
    Khirurgiia (Mosk); 2011; (4):47-50. PubMed ID: 21728254
    [No Abstract]   [Full Text] [Related]  

  • 12. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia].
    Zadnipryanyi IV; Tretyakova OS; Sataeva TP
    Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia].
    Tumanyan SV; Shepelenko AV; Chekmezova SA
    Khirurgiia (Mosk); 2018; (11):44-48. PubMed ID: 30531753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
    Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
    Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
    Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
    Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
    Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological correction of hypoxia in patients with severe carbon monoxide poisoning].
    Shilov VV; Andrianov AIu; Vasil'ev SA; Batotsyrenova KhV; Loladze AT
    Georgian Med News; 2012 Apr; (205):31-8. PubMed ID: 22665729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.